Vyvanse is a more potent stimulant than phentermine. It converts into dextroamphetamine in the body, producing stronger effects on dopamine, norepinephrine, and serotonin. Phentermine is a milder amphetamine-like stimulant designed with a chemical modification that specifically lowers its central nervous system activation compared to full amphetamines. But “stronger” doesn’t necessarily mean “better for you,” because these two drugs are approved for entirely different purposes and carry different risks.
How Each Drug Works in the Brain
Vyvanse (lisdexamfetamine) is a prodrug, meaning it’s inactive when you swallow it. Your body has to break it down, converting it into dextroamphetamine before it does anything. That conversion process is what gives Vyvanse its gradual onset and long-lasting effects. Once active, dextroamphetamine increases levels of dopamine, norepinephrine, and serotonin by pushing these chemicals out of nerve endings and into the spaces between neurons. This produces broad, powerful stimulation across multiple brain systems.
Phentermine works through a similar release mechanism for dopamine and norepinephrine, but it has a structural tweak on its chemical backbone that reduces how strongly it activates the central nervous system. Think of it as a dialed-down version of amphetamine. It still suppresses appetite and increases alertness, but with less intensity than a full amphetamine like the one Vyvanse delivers.
They’re Approved for Different Conditions
This is the most important practical distinction between the two. Vyvanse is FDA-approved for ADHD in adults and children age 6 and older, and for moderate to severe binge eating disorder in adults. Its prescribing label explicitly states that it is “not indicated or recommended for weight loss,” and that its safety and effectiveness for treating obesity have not been established.
Phentermine, on the other hand, is approved specifically as a short-term weight loss aid. It’s one of the oldest prescription diet medications still in use and is typically prescribed for a limited period, often 12 weeks or less. Vyvanse has no such time restriction and is commonly taken for months or years to manage ADHD or binge eating disorder.
This matters if you’re comparing them for weight management. Even though Vyvanse often causes weight loss as a side effect (children and adolescents with obesity who took it saw their BMI drop significantly over two years in clinical studies), prescribing it purely for that purpose is off-label and not supported by its FDA approval.
Duration and Onset
Vyvanse lasts considerably longer than phentermine in a single dose. Clinical studies show it improves attention for up to 14 hours in adults, with peak effects hitting around 3.5 to 4.5 hours after you take it. In children ages 6 to 12, it starts working within about 1.5 hours and lasts up to 13 hours. That extended duration is a direct result of its prodrug design: your body can only convert it into active amphetamine so fast, which stretches the effect across most of the day.
Phentermine’s effects are shorter. Most formulations last roughly 8 to 12 hours depending on the version, with immediate-release forms wearing off faster. This is part of why phentermine is sometimes taken twice daily, while Vyvanse is always a once-daily medication taken in the morning.
Side Effects Are Similar but Not Identical
Both drugs share a common set of stimulant side effects. In clinical trials of Vyvanse at doses of 50 to 70 mg per day, dry mouth affected 52% of patients, decreased appetite hit 25%, and insomnia occurred in about 19%. Roughly 1.5% experienced serious adverse effects.
Phentermine produces a similar profile. When studied in combination with topiramate (a common pairing), dry mouth affected about 52% of patients and insomnia around 28%. On its own, phentermine is generally associated with milder side effects than Vyvanse because of its lower potency, but individual responses vary.
Both medications raise resting heart rate and blood pressure. A meta-analysis of adult stimulant trials found average increases of about 5.7 beats per minute in heart rate and 2 mmHg in systolic blood pressure. These numbers sound small, but they can matter for people with existing cardiovascular risk. Combining the two drugs is specifically discouraged. A case report published in the NIH’s PMC documented a patient who developed a serious heart condition (a type of stress-induced heart failure) from using phentermine and Vyvanse together. The combination is not FDA-approved for any condition.
DEA Scheduling and Abuse Potential
Vyvanse is classified as a Schedule II controlled substance, the same category as oxycodone and methylphenidate. This reflects its high potency and significant potential for dependence. Phentermine is a Schedule IV controlled substance, a category that indicates lower abuse potential. This scheduling difference aligns with their pharmacology: Vyvanse delivers a full amphetamine, while phentermine’s modified structure makes it less rewarding to the brain’s dopamine system.
The prodrug mechanism of Vyvanse does offer some built-in abuse deterrence. Because your body has to convert it before it becomes active, snorting or injecting it doesn’t produce the rapid high that other amphetamines can. But once converted, it’s still dextroamphetamine, and the risk of psychological and physical dependence is real with long-term use.
Dosing Differences
Vyvanse is prescribed at 30 mg per day as a starting dose, with adjustments in 10 to 20 mg increments up to a maximum of 70 mg per day. For binge eating disorder, the target dose is typically 50 to 70 mg per day. Phentermine is usually prescribed at 15 to 37.5 mg per day, depending on the formulation.
Comparing milligrams between these two drugs isn’t meaningful because they have different potencies, different active compounds, and different rates of absorption. A 37.5 mg dose of phentermine is not “half as strong” as a 70 mg dose of Vyvanse. They’re simply different drugs acting at different intensities on overlapping but distinct pathways.
Which One Is Right for You
If you’re comparing these medications because you want help with weight loss, phentermine is the one actually approved for that purpose, though only for short-term use. If you’re taking Vyvanse for ADHD or binge eating disorder and noticing weight loss, that’s a recognized side effect rather than the drug’s intended function. Some clinicians do prescribe Vyvanse off-label for weight management, but the FDA has not endorsed this use and has specifically flagged concerns about using stimulants for weight loss due to cardiovascular risks.
If the question is purely about pharmacological strength, Vyvanse is the more potent drug. It produces stronger central nervous system stimulation, lasts longer, carries a higher abuse classification, and affects a broader range of brain chemicals. But potency alone doesn’t determine which medication is appropriate. Phentermine’s lower intensity is by design, matched to its purpose as a short-term appetite suppressant rather than a medication meant to reshape attention and impulse control over the long term.